Introduction
The choroid is the vascular layer of the eye and it provides oxygen and nourishment to the outer layers of the retina. Changes in the choroidal circulation may be related to the pathogenesis of retina, retina pigment epithelium, choroid, and optic nerve. These disorders include hyperopia, 1 myopia, 2 central serous chorioretinopathy, 3 polypoidal choroidal vasculopathy, 4 age-related macular degeneration, 5 inflammatory eye diseases, 6 diabetes, 7 glaucoma, 8 and scleral buckling surgery. 9 The enhanced depth imagingoptical coherence tomography (EDI-OCT) method of spectral domain optical coherence tomography (SD OCT) has enabled the quantitive measurement of choroidal thickness or volume, in addition to obtaining crosssectional images of choroid. 10, 11 Graves orbitopathy (GO), a disorder of autoimmune activity against orbital fibroblasts and adipocytes, is characterized by edema and inflammation of extraocular muscles and an increase in orbital connective tissue and fat. The immune basis of disease is suggested by perivascular and diffuse infiltration of CD4+ and CD8+ T cells, B cells, plasma cells, and macrophages. 12 Connective tissues are extensively remodeled with enlargement of the extraocular muscle, muscles, and orbital adipose tissues. The mass effect causes venous obstruction and congestion.
The aim of this study is to investigate whether the changes in the orbital tissues alter the choroidal circulation and subfoveal choroidal thickness in patients with GO.
In addition, we aimed to evaluate weather the changes in choroidal thickness correlate with the visual-evoked potential (VEP) measurements and Visual Field examinations of the patients with GO. 
Materials and methods
Sixty-two eyes of 31 patients with a diagnosis of GO participated in this prospective study. All patients were euthyroid in both clinical and laboratory examinations. None of the patients were using systemic steroids. The patients were compared with 44 eyes of 22 control subjects who did not have any ophthalmologic or systemic pathology. The study received approval from the Kocaeli University, Faculty of Medicine Ethics Committee. An informed consent was obtained from the patients.
Ophthalmologic examination
All patients and control subjects received comprehensive ocular examination including best-corrected visual acuity, biomicroscopic examination, intraocular pressure (IOP) measurement, indirect ophthalmoscopy, Hertel measurements, and choroidal thickness measurements. The patients with GO additionally underwent visual field tests and VEP measurements.
Clinical activity scores (CAS) of the patients were also evaluated. Patients received one point from each of the symptoms including spontaneous eye pain, eye pain upon eye movement, eyelid swelling, eyelid erythema, conjunctival redness, chemosis, and swollen caruncle. When CAS was 3 points or over, it was defined as active GO.
Exclusion criteria were suggestion of inflammatory orbital disease except GO, previous orbital radiotheraphy, high myopia (greater than − 6 diopters), high IOP (421 mm Hg), and ocular disases that effect choroidal thickness (glaucoma, uveitis, retinal and choroidal diseases).
OCT examination
Choroidal thickness was measured using EDI-OCT imaging using spectral domain OCT (Spectralis; Heidelberg Engineering, Heidelberg, Germany). To obtain an EDI-OCT image, the instrument was brought increasingly closer to the eye until we obtained an inverted image. Choroidal thickness, defined as the distance from the inferior margin of the retinal pigment epithelium to the choroid/sclera border was measured at central fovea. After the EDI image is obtained, two blinded clinicians measured the choroidal thickness manually by using calipers. Mean of the two measurements of each patient were taken into consideration. Choroidal thickness was measured at the central fovea (Figure 1 ).
VEP examination
VEP is defined as variation of bioelectrical potentials in the visual cortex evoked by visual stimuli and evaluates the transmission of neuronal impulses that originate from the retinal photoreceptors passing through visual pathways to the occipital cortex. VEP is obtained by averaging the responses from occipital scalp electrodes generated by 100 or more sequential stimuli. The VEP is generated using a black-white checkered-board pattern on a television monitor. Patients sat one meter away from the monitor. The patients' gaze was fixed on a point at the center of the television monitor monocularly. The bioelectric signal was filtered (bandpass 0.5-200 Hz). Two hundred responses were averaged for every trial (Neuropack Nihon Kohden, MEB-5504 K, Tokyo, Japan). The analysis time was 250 msec. Sweep length was 300 msec (30 msec/div) and stimulus rate was 1 Hz. Peak latencies of the P100 component were measured.
Statistical analysis
All statistical analyses were performed using software IBM SPSS Statistics 19.0 version (SPSS, Inc., Chicago, IL, USA). The results were reported as mean values ± SD. Choroidal measurements of the GO and control eyes were compared by using independent samples t test. The significance of correlations between the choroidal thickness, VEP, mean deviation (MD) of visual field and CAS were determined by Pearson's correlation coefficient test. A Po0.05 was considered statistically significant.
Results
Mean age of the GO group and controls were 44.13 ± 2.2 and 45.3 ± 3.1, respectively (P = 0.747). Twenty-four patients were female and 8 patients were male in the GO group. There was no statistical difference in gender between the groups (P40.05). Eleven patients demonstrated the CAS evaluated as 0, six patients as 1, five patients as 2, five patients as 3, and four patients as 4. 
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There was no patient with CAS of 5,6 or 7. None of the patients had decrease in visual acuity related with the GO. The IOP of the patients were within the normal limits. The clinical characteristics of the patients were summarized in Table 1 .
The mean choroidal thickness was 377.8 ± 7.4 μ in the GO group, and 334 ± 13.7 μ in the control group (P = 0.004). We correlated the CAS of the patients with their choroidal thickness. We observed that choroid was thicker in patients with higher CAS. The correlation between these two parameters were statistically significantly different (r ¼ 0.281, P ¼ 0.027; Figure 2) .
We correlated the VEP measurements of the patients with their choroidal thickness. We found that choroid was thicker in patients with elongated VEPp100 measurements (r ¼ 0.439, P ¼ 0.001; Figure 3 ).
We also evaluated the correlation between choroidal thickness and MD in visual field examination. The choroid thickness increased as the MD decreased. However, this correlation did not reach to the statistical significance (r = − 0.273, P = 0.061).
Discussion
OCT is a non-invasive method that is used for quantitive assessment of retinal morphology, and it offers valuable data about the prognosis of the patients. A relatively new technique, EDI-OCT uses light with a longer wavelength, which is more effective for choroidal scanning and provides valuable data about choroidal morphology. Recently, many SD OCT instruments have been used the EDI method for the chorodal thickness measurements in various diseases. 3, 13, 14 Changes in the choroidal thickness might be related to the pathogenesis of retinal, retina pigment epithelium, and optic nerve diseases. These studies reported increased choroidal thickness in patients Choroidal Thickness Figure 2 The choroidal thicknesses of the patients with GO were correlated with their clinical activity scores. There was a correlation between these two parameters and this correlation was statistically significant (r ¼ 0.281, P ¼ 0.027). 
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Enhanced depth imaging OCT in patients with GO B Özkan et al with posterior uveitis including Vogt-Koyanagi Harada disease, multiple evanescent white dot syndrome and Behcet's disease. [15] [16] [17] In this study we found that subfoveal choroidal thickness of eyes with GO was significantly higher than normal eyes. Patients with GO commonly have evidence of both extra-ocular muscle and orbital adipose tissue involvement. The hallmark of GO is swelling of the extraocular muscles in association with an increase in orbital connective tissue and fat volume to a variable extend. The expanded orbital tissues causes increase in intra-orbital pressure. As a result, the venous outflow from the orbit is impeded. 18 Elevated episcleral venous pressure value has been demonstrated in GO, and raised retrobulbar pressure above normal venous pressure has been reported as a possible cause of reduced orbital venous drainage. 19, 20 Konuk et al 21 found that the superior ophthalmic vein blood flow velocity was significantly lower in severe GO cases compared with modere and mild ones. The increase in venous pressure may lead to an elevation with IOP in some patients with GO. 22 In addition, it has been show that orbital decompression reduces the IOP and superior ophthalmic vein velocity significantly. 23 None of our patients had severe GO, and the mean IOP was within the normal limits. However, the mean choroidal thickness was elevated. We think that choroidal thickness might be affected from the venous obstruction and congestion in patients with GO. The elevation of the choroidal thickness might be an early sign of venous congestion that occurs before the elevation of IOP.
Another mechanism that might alter the thickness of choroid might be the direct compression of the globe. Chroidal folds might occur with extraocular process that induces sufficient compressive stress within the choroid. 24 Jorge et al 25 reported that choroidal folds might resolve and visual acuity might increase after orbital decompression for GO despite persistent enlargement of extraocular muscles. They claim that tension on the choriocapillaris could be generated by direct pressure on the sclera by enlarged eye muscles. 25 Odrobina et al 9 found that subfoveal choroidal thickness of eyes after scleral buckling surgery using an encircling band, in longterm observation, was significantly thicker. They claim that scleral buckling reduces blood flow and increases hemostasis in choroidal circulation. This may cause an elevation in choroidal pressure and may increase the subfoveal choroidal thickness. 9 The compression of the optic nerve by an orbital apex crowding often results with the optic neuropathy in patients with GO. This condition occurs in~5% of the patients with GO. 26 It might be asymptomatic with good vision, but it might also manifest with decreased visual acuity, reduced color vision, visual field defects, or afferent pupillary defects. If these symptoms and signs are not present, the patient might be unaware of visual loss until advanced clinical changes have occurred. VEP might help us gaining objective information about the optic nerve dysfunction in GO. [27] [28] [29] Weis et al 30 evaluated the relationship between the orbital bony geometry and the volume of the intraorbital structures in predicting optic neuropathy in GO. They found that medial rectus muscle size was a predictor of compressive optic neuropathy. 30 As compression on the optic nerve is also related with the stasis in the choroid, we hypothesize that increase in extra-ocular volume might also be related with the increase in choroidal thickness. In our study, none of the patients had the clinical signs of optic neuropathy. However, we found that choroid was thicker in patients with longer VEP latency. We believe that choroidal thickness measurements might be used to discriminate the early changes in optic nerve in patients with GO. Further investigations are needed to understand the relationship between these two parameters.
GO is an inflammatory and autoimmune disorder of the orbit. The immune basis of the disease is composed by a perivascular and diffuse infiltration of CD4+ and CD8+ T cells, B cells, plasma cells, and macrophages. 31 Orbital fibroblasts are thought to have crucial role in the pathogenesis by their ability to produce hydrophilic glycosaminoglycans that result in retention of fluid and edematous swelling of orbital tissues. The immune activity of ophthalmopathy is neither synonymous nor coincident with clinical severity of the disease. 32 Several methods have been proposed to evaluate disease activity; none has yet become generally accepted for routine use in clinical practice. The CAS has been shown to be a useful method, in spite of sensitivity and inter-observer variation weakness. Mourits et al 33 found good correlation between initial and post immune-suppressive treatment CAS. In another study, Tortora et al 34 evaluated correlation between the orbital MRI imaging and CAS. They found a statistical correlation between CAS and both STIR and contrast enhanced T1-weighted sequences. 34 In our study, we found that choroid was thicker in patients with higher CAS. However, our patients' CAS scores were distributed between 0 and 4. We believe that comparison of choridal thickness of the patients with higher CAS might give a better idea in relationship between CAS and choroidal thickness. Absence of patients with higher CAS might be considered as a weakness in our study.
In conclusion, we found that patients with GO have higher choroidal thickness than the healthy controls, and we observed that choroid was thicker in patients with higher CAS. In addition, VEP measurements of the patients were correlated with the choroidal thickness of the patients. Choroidal thickness measurement might be a beneficial test for evaluating GO, and discriminating optic Eye Enhanced depth imaging OCT in patients with GO B Özkan et al neuropathy. The patients in our study did not have severe GO and they did not have high CAS. We believe that further investigations with a larger and variable group of patients would show more disease-specific results.
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